You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The newly launched EndPandemic National Data Consortium brings together seven life sciences and bioinformatics firms in search of treatments and vaccines.
The Cold Spring Harbor Laboratory spinout will build predictive models for lung cancer progression and risk using its SpliceCore software platform.
Big Blue's IBM Research and Watson divisions are teaming with several national consortia to unlock and share molecular and clinical coronavirus data on HPC platforms.
This new partnership between Harvard's Chan School of Public Health and the Human Vaccines Project seeks to apply AI and genomics to accelerate vaccine development.
The new NferX platform applies AI to single-cell RNA-seq and clinical data to help pinpoint coronavirus transmission and receptor pathways.
The project's total budget is expected to exceed $1.5 million with backing from the Israeli Innovation Authority and international technology firm BATM.
The precision medicine center at Colorado's UCHealth expects to add 100,000 participants annually and have 17 drug-gene pairs for pharmacogenomics this year.
Second Genome will use its Microbiome Analytics platform to identify novel biomarkers linked to clinical responses to Gilead's investigational medicines.
The health system said that the program is encouraging patient compliance and increasing revenues and savings.
The EHR vendor is re-engineering its architecture to increase interoperability with genetic labs and merge genomic and pathology information at the point of care.
Illumina, LabCorp, and Providence healthcare will join the effort to collect COVID-19 patient samples in the US for immune cell receptor sequencing.
The firms are developing clinical and RUO workflows that use NGS for pathogen identification and will comarket IDbyDNA's Explify data platform.
The precision medicine company also is accelerating its push into diabetes, depression, and cardiology after getting its solid-tumor test turnaround down to 9 days.
The effort is focused on building an atlas of immune cell types found across a range of Asian population groups as part of the Human Cell Atlas project.
Now valued at $5 billion, the company will apply the new funding to continue its expansion in diabetes, depression, and cardiology.
Invitae said YouScript and Genelex will enable it to provide pharmacogenomic testing, while Diploid will help interpret WGS results.
After pilot programs showed patients and physicians are interested in genomics, NorthShore is working on "hardwiring" genetics into routine care.
The companies have agreed to combine their respective offerings into a single services package for drug target identification and validation.
The multi-omics translational software developer is helping the Crohn's & Colitis Foundation validate its research into biomarkers that can predict complications requiring surgery.
The computer technology firms will provide BGI Genomics with computational equipment and expertise to support its studies into the genomics of the virus.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.